The latest plain language summary of publication from Neurodegenerative Disease Management describes the findings from an international committee of 10 MS experts who developed recommendations to answer questions about COVID-19 vaccines in people with MS taking cladribine tablets.
Read the full article here.
The original article on which this summary is based is called ‘Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice’ and was originally published in the journal Therapeutic Advances in Neurological Disorders. The original article can be read here.